临床宏基因组学下一代测序自动化解决方案的概念验证研究。
A proof-of-concept study of an automated solution for clinical metagenomic next-generation sequencing.
作者信息
Luan Y, Hu H, Liu C, Chen B, Liu X, Xu Y, Luo X, Chen J, Ye B, Huang F, Wang J, Duan C
机构信息
Department of Clinical Laboratory, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
出版信息
J Appl Microbiol. 2021 Aug;131(2):1007-1016. doi: 10.1111/jam.15003. Epub 2021 Feb 2.
AIMS
Metagenomic next-generation sequencing (mNGS) has been utilized for diagnosing infectious diseases. It is a culture-free and hypothesis-free nucleic acid test for diagnosing all pathogens with known genomic sequences, including bacteria, fungi, viruses and parasites. While this technique greatly expands the clinical capacity of pathogen detection, it is a second-line choice due to lengthy procedures and microbial contaminations introduced from wet-lab processes. As a result, we aimed to reduce the hands-on time and exogenous contaminations in mNGS.
METHODS AND RESULTS
We developed a device (NGSmaster) that automates the wet-lab workflow, including nucleic acid extraction, PCR-free library preparation and purification. It shortens the sample-to-results time to 16 and 18·5 h for DNA and RNA sequencing respectively. We used it to test cultured bacteria for validation of the workflow and bioinformatic pipeline. We also compared PCR-free with PCR-based library prep and discovered no differences in microbial reads. Moreover we analysed results by automation and manual testing and found that automation can significantly reduce microbial contaminations. Finally, we tested artificial and clinical samples and showed mNGS results were concordant with traditional culture.
CONCLUSION
NGSmaster can fulfil the microbiological diagnostic needs in a variety of sample types.
SIGNIFICANCE AND IMPACT OF THE STUDY
This study opens up an opportunity of performing in-house mNGS to reduce turnaround time and workload, instead of transferring potentially contagious specimen to a third-party laboratory.
目的
宏基因组下一代测序(mNGS)已用于传染病诊断。它是一种无需培养且无假设的核酸检测方法,可用于诊断所有具有已知基因组序列的病原体,包括细菌、真菌、病毒和寄生虫。虽然这项技术极大地扩展了病原体检测的临床能力,但由于操作流程冗长以及湿实验室过程中引入的微生物污染,它是二线选择。因此,我们旨在减少mNGS的实际操作时间和外源性污染。
方法与结果
我们开发了一种设备(NGSmaster),可自动执行湿实验室工作流程,包括核酸提取、无PCR文库制备和纯化。它将DNA和RNA测序的样本到结果时间分别缩短至16小时和18.5小时。我们用它来测试培养的细菌,以验证工作流程和生物信息学流程。我们还比较了无PCR文库制备和基于PCR的文库制备,发现微生物读数没有差异。此外,我们通过自动化和手动测试分析结果,发现自动化可以显著减少微生物污染。最后,我们测试了人工和临床样本,结果表明mNGS结果与传统培养结果一致。
结论
NGSmaster可以满足各种样本类型的微生物诊断需求。
研究的意义和影响
本研究提供了一个进行内部mNGS的机会,以减少周转时间和工作量,而不是将潜在传染性样本转移到第三方实验室。